Remove DEA Remove Legislation Remove Programs
article thumbnail

ASA offers solution to DOJ research block: Our comments on the DEA’s proposed rules

Americans for Safe Access

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

article thumbnail

Congressional Committee to Hold Marijuana Legislative Hearing This Wednesday

NORML

This Wednesday, January 15th, at 10 am EST, the House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). Douglas Throckmorton, M.D., Volkow, M.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NORML “Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions”

Cannabis Law Report

Legislation unanimously passed by members of the US Senate empowers the US Attorney General to facilitate clinical research trials involving cannabis. 253 in the final weeks of the legislative session. Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions.

article thumbnail

House Energy and Commerce Subcommittee Considers ‘Cannabis Policies for the New Decade’

NORML

Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. Witnesses at today’s hearing were: Matthew J. Douglas Throckmorton, M.D.,

Policy 197
article thumbnail

DEA Faces Lawsuit For Denying End of Life Patients the Right to Try Psychedelics Therapy

Veriheal

The FDA refers to this program as the expanded access program on their website. While they offer approved clinical trials that can offer patients the ability to try potential therapeutic options, many patients are unable to participate in clinical trials, and this is where the importance of the Right to Try programs comes into play.

Therapy 64
article thumbnail

The Week in Weed: September 29, 2023

The Blunt Truth

Sure, this is further than the legislation has gotten before, but there’s still a LONG way to go on this. MORE & HOPE Banking isn’t the only cannabis-related legislation working its way through the halls of Congress. MORE & HOPE Banking isn’t the only cannabis-related legislation working its way through the halls of Congress.

Banking 93
article thumbnail

The Week in Weed: May 8, 2020

The Blunt Truth

The Department of Justice’s Office of Legal Counsel released a memo finding that the Drug Enforcement Administration’s cannabis research program is non-compliant with international drug laws. This may provide some context for the DEA’s recent proposed rules overhauling its research program. handy dandy chart.

DEA 101